Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
of
.
Show all posts
Showing posts with label
of
.
Show all posts
Wednesday, August 5, 2026
Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-Positive NSCLC
›
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically pr...
Tuesday, July 7, 2026
FDA Approves Icotyde (icotrokinra) for the Treatment of Plaque Psoriasis
›
Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved Icotyde (icotrokinra), an in...
Tuesday, June 30, 2026
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
›
Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmace...
Tuesday, June 16, 2026
Lilly's announces results from Phase III clinical trial of Jaypirca
›
In continuation of my update on pirtobrutinib Eli Lilly and Company announced results from the Phase 3 BRUIN CLL-322 clinical trial of Jayp...
›
Home
View web version
